The Pulse
Three things shaping AI in healthcare this fortnight:
Microsoft, Google and xAI will let the government test their AI models before launch — The U.S. government is partnering directly with major tech companies to evaluate models before release and continue monitoring them after deployment, signaling a more active era of AI oversight. (CNN, 2026)
UnitedHealth to remove annoying barrier for slew of medical procedures — UnitedHealth says it will use AI to reduce or eliminate prior authorization requirements for certain tests, surgeries, and therapies, reflecting how AI is increasingly being integrated into administrative decisions that affect patient access to care. (California Post, 2026)
AI Slop Is Flooding Academic Journals. A Top Journal Measured It — Researchers are beginning to quantify how generative AI is affecting scientific publishing, with early evidence suggesting higher volumes of lower-quality submissions and less informative peer review content. (Forbes, 2026)
Takeaway: AI is moving from experimental use into core systems like regulation, healthcare administration, and scientific publishing, forcing institutions to focus more on oversight, quality, and accountability.
Psychology & Behavioral Health
Pennsylvania suing Character AI, claiming chatbot posed as a medical professional (CBS News, 2026)
Pennsylvania officials are challenging whether AI chatbots can legally present themselves as healthcare professionals, especially when users may interpret responses as legitimate clinical advice. The case centers on allegations that a chatbot identified itself as a licensed psychiatrist, discussed depression, and suggested medication guidance despite lacking valid credentials. The lawsuit highlights growing pressure for clearer boundaries between conversational AI and regulated mental health practice.
Clinician Cue: Patients may increasingly encounter AI systems that blur the line between support tool and provider, making digital literacy and clarification of professional roles more important in clinical conversations.
'Think outside the bots': How to stop AI from turning your brain to mush (BBC, 2026)
Researchers and commentators are raising concerns that heavy AI reliance may weaken attention, memory, creativity, and critical thinking over time. Early studies suggest that people who depend more on AI tools may engage less deeply with information and produce more predictable ideas, especially when they already feel uncertain about a topic. The article argues that healthier AI use involves keeping humans actively involved in reflection, note-taking, and decision-making rather than outsourcing thinking entirely.
Clinician Cue: AI may help reduce workload, but maintaining reflective thinking and independent clinical reasoning will remain essential skills for behavioral health professionals.
Medicine & Clinical Innovation
Federal vs. state AI rules: What payers need to know (Becker’s Payer, 2026)
AI oversight in healthcare is becoming increasingly fragmented as states introduce their own rules for claims review and prior authorization. At the same time, federal protections and existing laws like ERISA and HIPAA leave gaps around how some AI systems are regulated, especially when third-party vendors are involved. The result is a growing patchwork of expectations around transparency, medical necessity, and accountability in payer decision-making.
Quick Win: Organizations using AI in utilization management should review whether human oversight, documentation, and patient-specific review processes are clearly defined and consistently applied.
Adoption of ChatGPT as a Drug Information Resource: A Community-Based Study Among Pharmacists (Dergi Park, 2026)
The study found that many pharmacists are already using Chat GPT to support tasks like dosage adjustments, interaction checks, and adverse reaction management. Most participants viewed the tool as useful and time-saving, though concerns about citation quality and reliability remained common. The findings reflect a broader shift toward AI-assisted workflows in frontline healthcare settings, even as trust and verification remain ongoing challenges.
Quick Win: Treat AI-generated drug information as a drafting or support tool, while maintaining independent verification through trusted clinical references before applying it in patient care.
Ethics & Oversight
Policy & Compliance: Federal agencies and major AI companies are moving toward ongoing pre-release model testing, signaling a more active regulatory approach to high-impact AI systems.
Bias & Transparency: Early evidence from academic publishing suggests that increased AI-generated content may reduce clarity and informational quality, raising concerns about transparency and evidence reliability.
Accountability & Governance: As AI tools take on larger roles in areas like prior authorization and behavioral health interactions, organizations may face growing pressure to define where human oversight remains essential.
Wayde AI Insight
This issue is really about boundaries. Across government-led model evaluation, health system workflows, behavioral health, and scientific publishing, AI is no longer sitting outside the room. It is starting to influence what gets reviewed, what gets approved, what patients are told, and what evidence is considered credible. That does not make AI inherently good or bad, but it does make structure more important. The institutions that handle this well will likely be the ones most explicit about roles, limits, and accountability, especially in settings where efficiency pressures can quietly outpace clinical judgment or methodological rigor. Over time, the key challenge may not be access to AI tools, but the discipline required to keep human reasoning visible in systems that increasingly default to automation.
If this was useful, feel free to pass it along.
Connect
Helping healthcare professionals adopt AI ethically and responsibly.
Produced by Wayde AI with AI assistance.